发明名称 PRODUCTION METHOD OF PHARMACEUTICAL COMPOSITION CONTAINING CANDESARTAN CILEXETIL
摘要 A production method of pharmaceutical composition contains candesartan cilexetil, comprising dissolving a water-soluble polymer and a sugar alcohol to purified water and dispersing candesartan cilexetil to prepare a dispersion liquid of candesartan cilexetil, granulating by a wet process using the dispersion liquid together with a powdery additive to obtain a granulated product, drying the granulated product, particle size regulating the granulated product; and tableting the granulated product, wherein the dispersion liquid contains the amount of water-soluble polymer within a range of 0.05 parts by weight or more and 0.5 parts by weight or less, based on 100 parts by weight of the pharmaceutical composition, and the dispersion liquid contains the amount of sugar alcohol within a range of 5 parts by weight or more and 20 parts by weight or less, based on 100 parts by weight of the pharmaceutical composition.
申请公布号 US2016250192(A1) 申请公布日期 2016.09.01
申请号 US201615148181 申请日期 2016.05.06
申请人 Sawai Pharmaceutical Co., Ltd. 发明人 FUKUHARA Yasushi;UETSUKI Kenji;NAKAGAWA Tomoya
分类号 A61K31/4184;A61K9/20 主分类号 A61K31/4184
代理机构 代理人
主权项 1. A production method of pharmaceutical composition containing candesartan cilexetil, comprising: dissolving a water-soluble polymer and a sugar alcohol to purified water and dispersing candesartan cilexetil to prepare a dispersion liquid of candesartan cilexetil; granulating by a wet process using the dispersion liquid together with a powdery additive to obtain a granulated product; drying the granulated product; particle size regulating the granulated product; and tableting the granulated product, wherein the dispersion liquid contains the amount of water-soluble polymer within a range of 0.05 parts by weight or more and 0.5 parts by weight or less, based on 100 parts by weight of the pharmaceutical composition, and the dispersion liquid contains the amount of sugar alcohol within a range of 5 parts by weight or more and 20 parts by weight or less, based on 100 parts by weight of the pharmaceutical composition.
地址 Osaka JP